Initial Management of Massive Ascites in a Patient with HCV History
For a patient presenting with massive ascites and HCV history, perform immediate large-volume therapeutic paracentesis with albumin replacement (8g per liter of ascites removed) as first-line treatment, followed by diagnostic paracentesis to rule out spontaneous bacterial peritonitis, then initiate sodium restriction and diuretic therapy. 1, 2
Immediate Diagnostic Workup
Perform diagnostic paracentesis on hospital admission in all cirrhotic patients with ascites to exclude spontaneous bacterial peritonitis and assess ascitic fluid characteristics. 1, 2
Essential Ascitic Fluid Analysis:
- Inoculate 10 ml of ascitic fluid into blood culture bottles at bedside to maximize bacterial detection. 1
- Obtain neutrophil count - if ≥250 cells/mm³, start empiric third-generation cephalosporin (e.g., cefotaxime) immediately for presumed SBP. 1, 3
- Calculate serum-ascites albumin gradient (SAAG) - if ≥1.1 g/dL, confirms portal hypertension as the cause with 97% accuracy. 1
- Measure total ascitic protein - if <15 g/L, the patient has increased risk of developing SBP. 1
Additional Laboratory Assessment:
- Check liver function tests, renal function (creatinine, BUN), serum electrolytes, and complete blood count. 1, 3
- Perform abdominal ultrasound to confirm ascites and assess liver morphology. 1
Immediate Therapeutic Intervention
Large-Volume Paracentesis:
Therapeutic paracentesis is the first-line treatment for massive ascites because it provides rapid, safe, and effective symptom relief with shorter hospitalization compared to diuretics alone. 1, 2
- Perform single-session large-volume paracentesis removing all ascites in one sitting rather than serial smaller paracenteses. 1
- Administer albumin at 8g per liter of ascites removed (approximately 100 ml of 20% albumin per 3 liters removed) once paracentesis is complete to prevent post-paracentesis circulatory dysfunction. 1, 2
- For paracentesis <5 liters, synthetic plasma expanders (150-200 ml of gelofusine or haemaccel) can be used instead of albumin. 1, 2
Critical pitfall: Failure to provide volume expansion after large-volume paracentesis leads to post-paracentesis circulatory dysfunction with renal impairment and electrolyte disturbances. 1
Ongoing Medical Management
Dietary Sodium Restriction:
Restrict dietary sodium to 90 mmol/day (5.2g salt/day) - a "no added salt" diet. 1, 2
Diuretic Therapy:
Start spironolactone 100 mg once daily as monotherapy for initial diuretic treatment. 1, 2
- Increase spironolactone by 100 mg every 3-7 days up to maximum 400 mg/day if inadequate response. 1, 2
- If spironolactone 400 mg/day fails to resolve ascites, add furosemide 40 mg/day, increasing up to 160 mg/day while maintaining a 100:40 mg ratio of spironolactone to furosemide. 1, 2
- Reinitiate diuretics 1-2 days after paracentesis - this does not increase risk of circulatory dysfunction and prevents rapid ascites reaccumulation (93% recurrence without diuretics vs. 18% with spironolactone). 1
Critical pitfall: Starting with furosemide monotherapy is less effective than spironolactone and should be avoided. 2
Monitoring Parameters:
- Target weight loss of 0.5 kg/day in patients without peripheral edema and 1 kg/day in those with edema. 2
- Monitor serum electrolytes, creatinine, and weight regularly (every 2-4 weeks initially). 4, 2
- Check spot urine sodium:potassium ratio to evaluate diuretic response (target 1.8-2.5). 2
Management of Hyponatremia During Treatment
Hyponatremia management algorithm based on severity: 1, 2
- Serum sodium 126-135 mmol/L with normal creatinine: Continue diuretics with close electrolyte monitoring; do not water restrict. 1, 2
- Serum sodium 121-125 mmol/L with normal creatinine: Consider stopping or reducing diuretics cautiously. 1, 2
- Serum sodium 121-125 mmol/L with elevated creatinine (>150 mmol/L): Stop diuretics immediately and give volume expansion. 1, 2
- **Serum sodium <120 mmol/L:** Stop diuretics and provide volume expansion with colloid or saline, avoiding sodium increase >12 mmol/L per 24 hours. 1, 2
Liver Transplantation Evaluation
All patients with cirrhotic ascites should be considered for liver transplantation referral because ascites development marks a significant worsening of prognosis (85% one-year survival, 56% five-year survival without transplant). 1, 2
- Early transplant evaluation is particularly important if the patient develops refractory ascites, SBP, or renal dysfunction. 1, 3
Important Contraindications
Avoid NSAIDs as they reduce urinary sodium excretion and can induce acute kidney injury. 4, 3